HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haojia Wu Selected Research

Small Nuclear RNA (snRNA)

1/2021Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis.
1/2019Advantages of Single-Nucleus over Single-Cell RNA Sequencing of Adult Kidney: Rare Cell Types and Novel Cell States Revealed in Fibrosis.
1/2019The single-cell transcriptomic landscape of early human diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haojia Wu Research Topics

Disease

5Fibrosis (Cirrhosis)
01/2021 - 01/2018
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2019
2Ureteral Obstruction
01/2020 - 01/2019
2Kidney Diseases (Kidney Disease)
01/2018 - 12/2017
1Hypoxia (Hypoxemia)
01/2022
1Atrophy
01/2021
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Chronic Renal Insufficiency
01/2021
1Inflammation (Inflammations)
01/2020
1Solitary Kidney
01/2018

Drug/Important Bio-Agent (IBA)

7RNA (Ribonucleic Acid)IBA
01/2021 - 12/2017
3Small Nuclear RNA (snRNA)IBA
01/2021 - 01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1SodiumIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1endoplasmic reticulum glycoprotein p72IBA
01/2021
1pigment epithelium-derived factorIBA
01/2021
1osteoblast cadherinIBA
01/2021
1Matrix Gla ProteinIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Long Noncoding RNAIBA
01/2020
1PotassiumIBA
01/2019
1Small Cytoplasmic RNAIBA
01/2019
1Nerve Growth Factor (NGF)IBA
01/2019

Therapy/Procedure

1Therapeutics
01/2022